Literature DB >> 22927469

Clinical features of schwannomatosis: a retrospective analysis of 87 patients.

Vanessa L Merker1, Sonia Esparza, Miriam J Smith, Anat Stemmer-Rachamimov, Scott R Plotkin.   

Abstract

BACKGROUND: Schwannomatosis is a recently recognized form of neurofibromatosis characterized by multiple noncutaneous schwannomas, a histologically benign nerve sheath tumor. As more cases are identified, the reported phenotype continues to expand and evolve. We describe the spectrum of clinical findings in a cohort of patients meeting established criteria for schwannomatosis.
METHODS: We retrospectively reviewed the clinical records of patients seen at our institution from 1995-2011 who fulfilled either research or clinical criteria for schwannomatosis. Clinical, radiographic, and pathologic data were extracted with attention to age at onset, location of tumors, ophthalmologic evaluation, family history, and other stigmata of neurofibromatosis 1 (NF1) or NF2.
RESULTS: Eighty-seven patients met the criteria for the study. The most common presentation was pain unassociated with a mass (46%). Seventy-seven of 87 (89%) patients had peripheral schwannomas, 49 of 66 (74%) had spinal schwannomas, seven of 77 (9%) had nonvestibular intracranial schwannomas, and four of 77 (5%) had intracranial meningiomas. Three patients were initially diagnosed with a malignant peripheral nerve sheath tumor; however, following pathologic review, the diagnoses were revised in all three cases. Chronic pain was the most common symptom (68%) and usually persisted despite aggressive surgical and medical management. Other common diagnoses included headaches, depression, and anxiety.
CONCLUSIONS: Peripheral and spinal schwannomas are common in schwannomatosis patients. Severe pain is difficult to treat in these patients and often associated with anxiety and depression. These findings support a proactive surveillance plan to identify tumors by magnetic resonance imaging scan in order to optimize surgical treatment and to treat associated pain, anxiety, and depression.

Entities:  

Mesh:

Year:  2012        PMID: 22927469      PMCID: PMC3481897          DOI: 10.1634/theoncologist.2012-0162

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  17 in total

1.  Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.

Authors:  J Antinheimo; R Sankila; O Carpén; E Pukkala; M Sainio; J Jääskeläinen
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

2.  Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.

Authors:  Miriam J Smith; Andrew J Wallace; Naomi L Bowers; Cecilie F Rustad; C Geoff Woods; Guy D Leschziner; Rosalie E Ferner; D Gareth R Evans
Journal:  Neurogenetics       Date:  2012-03-22       Impact factor: 2.660

Review 3.  Diagnostic criteria for schwannomatosis.

Authors:  M MacCollin; E A Chiocca; D G Evans; J M Friedman; R Horvitz; D Jaramillo; M Lev; V F Mautner; M Niimura; S R Plotkin; C N Sang; A Stemmer-Rachamimov; E S Roach
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

Review 4.  Schwannomatosis: a clinical and pathologic study.

Authors:  M MacCollin; W Woodfin; D Kronn; M P Short
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.

Authors:  L B Jacoby; D Jones; K Davis; D Kronn; M P Short; J Gusella; M MacCollin
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

6.  The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey.

Authors:  M P Vanderpump; W M Tunbridge; J M French; D Appleton; D Bates; F Clark; J Grimley Evans; D M Hasan; H Rodgers; F Tunbridge
Journal:  Clin Endocrinol (Oxf)       Date:  1995-07       Impact factor: 3.478

7.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08

8.  Familial schwannomatosis: exclusion of the NF2 locus as the germline event.

Authors:  M MacCollin; C Willett; B Heinrich; L B Jacoby; J S Acierno; A Perry; D N Louis
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

9.  Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.

Authors:  D M Parry; R Eldridge; M I Kaiser-Kupfer; E A Bouzas; A Pikus; N Patronas
Journal:  Am J Med Genet       Date:  1994-10-01

10.  Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.

Authors:  Daphne L Wang; Kelly B Smith; Sonia Esparza; Fawn A Leigh; Alona Muzikansky; Elyse R Park; Scott R Plotkin
Journal:  Genet Med       Date:  2012-08-09       Impact factor: 8.822

View more
  60 in total

Review 1.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

2.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

Review 3.  Musculoskeletal and overgrowth syndromes associated with cutaneous abnormalities.

Authors:  Bahar Dasgeb; Michael A Morris; Christina M Ring; Darius Mehregan; Michael E Mulligan
Journal:  Br J Radiol       Date:  2016-09-16       Impact factor: 3.039

4.  CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.

Authors:  Brigitte C Widemann; Maria T Acosta; Sylvia Ammoun; Allan J Belzberg; Andre Bernards; Jaishri Blakeley; Antony Bretscher; Karen Cichowski; D Wade Clapp; Eva Dombi; Gareth D Evans; Rosalie Ferner; Cristina Fernandez-Valle; Michael J Fisher; Marco Giovannini; David H Gutmann; C Oliver Hanemann; Robert Hennigan; Susan Huson; David Ingram; Joe Kissil; Bruce R Korf; Eric Legius; Roger J Packer; Andrea I McClatchey; Frank McCormick; Kathryn North; Minja Pehrsson; Scott R Plotkin; Vijaya Ramesh; Nancy Ratner; Susann Schirmer; Larry Sherman; Elizabeth Schorry; David Stevenson; Douglas R Stewart; Nicole Ullrich; Annette C Bakker; Helen Morrison
Journal:  Am J Med Genet A       Date:  2014-01-17       Impact factor: 2.802

5.  Plexiform Schwannoma of the Oral Cavity: Report of Eight Cases and a Review of the Literature.

Authors:  Angela C Chi; Brad W Neville; Lisa Cheng
Journal:  Head Neck Pathol       Date:  2020-04-08

6.  A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas.

Authors:  Rosario Caltabiano; Gaetano Magro; Agata Polizzi; Andrea Domenico Praticò; Andrea Ortensi; Valerio D'Orazi; Andrea Panunzi; Pietro Milone; Luigi Maiolino; Francesco Nicita; Gabriele Lorenzo Capone; Roberta Sestini; Irene Paganini; Mariella Muglia; Sebastiano Cavallaro; Salvatore Lanzafame; Laura Papi; Martino Ruggieri
Journal:  Childs Nerv Syst       Date:  2017-04-01       Impact factor: 1.475

Review 7.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

8.  Sporadic NF2 Mosaic: Multiple spinal schwannomas presenting with severe, intractable pain following pregnancy.

Authors:  Jeffrey H Zimering; Bryan D Choi; Matthew J Koch; John C Dewitt; Anat Stemmer-Rachamimov; John H Shin
Journal:  Interdiscip Neurosurg       Date:  2017-12

9.  [Schwannoma of the femoral nerve: a rare differential diagnosis of leg pain].

Authors:  P Schulte; I E Sandalcioglu; F Grabellus; H Baba; U Sure; M Jäger
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

10.  Multiple Schwannomas of the Spine: Review of the Schwannomatosis or Congenital Neurilemmomatosis: A Case Report.

Authors:  Sang-Hoon Lee; Se-Hoon Kim; Bum-Joon Kim; Dong-Jun Lim
Journal:  Korean J Spine       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.